¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fatty acid oxidation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • tartaric acid
    Ÿ¸£Å¸¸£»ê
  • uric acid
    ¿ä»ê
  • uric acid infarct
    ¿ä»ê°æ»ö
  • uric acid nephropathy
    ¿ä»ê¿°ÄáÆÏº´(Áõ), ¿ä»ê¿°½ÅÀ庴(Áõ)
  • uric acid stone
    ¿ä»êµ¹
  • uridine diphosphate glucuronic acid
    ÀÌÀλê¿ì¸®µò±Û·çÄí·Ð»ê
  • urocanic acid
    ¿ì·ÎÄ­»ê
  • uronic acid
    ¿ì·Ð»ê
  • ursodeoxycholic acid
    ¿ì¸£¼Òµ¥¿Á½ÃÄÝ»ê
  • volatile acid
    Èֹ߼º»ê
  • valproic acid
    ¹ßÇÁ·Î»ê
  • vanillylmandelic acid
    ¹Ù´Ò¸±¸¸µ¨»ê
  • xanthurenic acid
    Å©»êÅõ·»»ê
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • citric acid cycle
    ±¸¿¬»êȸ·Î
  • conjugate acid
    °áÇÕ»ê(Ì¿ùêß«)
  • conjugate acid
    ¦»ê(¡­ß«).
  • conjugated acid
    ¦»ê, °ø¾×»ê, °áÇÕ»ê.
  • corrosive acid
    ºÎ½Ä»ê(ݯãÚß«).
  • cyanuric acid
    ½Ã¾Æ´©¸£»ê(¡­ß«).
  • cyclopaldic acid
    ½ÃŬ·ÎÆÈµå»ê(¡­ß«).
  • dehydroascorbic acid
    Å»¼ö¼Ò¾Æ½ºÄÚ¸£ºó»ê.
  • delta-aminolevulinic acid
    µ¨Å¸-¾Æ¹Ì³ë·¹ºÒ¸°»ê
  • delta-aminolevulinic acid
    µ¨Å¸-¾Æ¹Ì³ë·¹ºÒ¸°»ê.
  • delta-aminolevulinic acid dehydrase
    µ¨Å¸-¾Æ¹Ì³ë·¹ºÒ¸°»êÅ»¼ö¼ÒÈ¿¼Ò<--µ¥È÷µå¶óÁ¦>
  • delta-aminolevulinic acid dehydrogenase
    µ¨Å¸-¾Æ¹Ì³ë·¹ºÒ¸°»êÅ»¼ö¼ÒÈ¿¼Ò<--µðÇÏÀ̵å·Î°Ô³ªÁ¦>
  • delta-aminolevulinic acid synthetase
    µ¨Å¸-¾Æ¹Ì³ë·¹ºÒ¸°»êÇÕ¼ºÈ¿¼Ò
  • deoxycholic acid
    µ¥¿Á½ÃÄݸ°»ê
  • deoxyribonucleic acid
    µ¥¿Á½Ã¸®º¸ÇÙ»ê
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • heterofermentative lactic acid bacteria
    ÀÌÁ¾¹ßÈ¿(ì¶ðúÛ£ý£) ¶ôÆ®»ê(ß«) ¹ÚÅ׸®¾Æ
  • hexuronic acid
    Çí½´·Ð »ê(ß«)
  • hippuric acid
    ¸¶´¢»ê(Ø©Òãß«)
  • homoamino acid
    È£¸ð¾Æ¹Ì³ë»ê(ß«)
  • homocodonic amino acid
    ±Õ(г)ÄÚµ· ¾Æ¹Ì³ë»ê(ß«)
  • homofermentative lactic acid bacteria
    µ¿Á¾¹ßÈ¿(ÔÒðúÛ£ý£) ¶ôÆ®»ê(ß«) ¹ÚÅ׸®¾Æ
  • homogentisic acid
    È£¸ðÁ¨Æ¾»ê(ß«)
  • hyaluronic acid
    ÇÏÀ̾ËÀ¯·Ð»ê(ß«)
  • hydroxy acid
    ÇÏÀ̵å·Ï½Ã»ê(ß«)
  • ¥â-hydroxybutyric acid
    ¥â-ÇÏÀ̵å·Ï½ÃºäƼ¸£»ê(ß«)
  • 5-hydroxyindoleacetic acid
    5-ÇÏÀ̵å·Ï½ÃÀε¹¾Æ¼¼Æ®»ê(ß«)
  • imino acid
    À̹̳ë»ê(ß«)
  • indispensable amino acid
    ºÒ°¡°á(ÝÕʦÌÀ) ¾Æ¹Ì³ë»ê(ß«)
  • indoleacetic acid
    Àε¹¾Æ¼¼Æ®»ê(ß«)
  • infectious nucleic acid
    °¨¿°¼ºÇÙ»ê(Êïæøàõú·ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
FNC fatty nutritional cirrhosis
PAS   1) Periodic Acid-Schiff Stain
  2) Para-Amino-Salicyclic Acid
 &nbs...
AAG 3-alkaladenine deoxyribonucleic acid glycosylase; allergic angiitis and granulomatosis; alpha-1-acid...
AHA acetohydroxamic acid; acquired hemolytic anemia; acute hemolytic anemia; American Heart Association;...
AP accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
[(14)C]-AA 14)C]-Arachidonic Acid
AIB 14C-amino isobutyric acid
AGP 1-Acid glycoprotein
ACC 1-Aminocyclopropane carboxylic acid
ACPC 1-Aminocyclopropane carboxylic acid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • uronic acid
    ¿ì·Ð»ê
    ´Ü´ç·ù ź¼Ò¼âÀÇ ¾ËÄݱ⠸»´ÜÀÇ »êÈ­¿¡ ÀÇÇØ »ý¼ºµÈ ¾Ëµ¥ÇÏÀ̵å»ê.
  • valproic acid
    ¹ßÇÁ·Î»ê, º§ÇÁ·ÎÀÍ»ê
    2-ÇÁ·ÎÇÊÆæÅ¸³ëÀÍ »ê. 8°³ÀÇ Åº¼Ò Ãø¼â¸¦ °®´Â Áö¹æ»ê. Ç×°£ÁúÁ¦ÀÌ´Ù.
  • vanillyl mandelic acid
    ¹Ù´Ò¸± ¸¸µ¨»ê
    Ä«Å×ÄݾƹÎÀÇ ¸¶Áö¸· ´ë»ç¹°.
  • vinylacetic acid
    ºñ´Ò ÃÊ»ê
  • volatile acid
    Èֹ߼º »ê
  • weak acid
    ¾à»ê
    ÇØ¸®µµ°¡ ³·Àº »ê
  • xanthenuric acid
    Ű»êÅ×´©¸£ »ê
    Æ®¸³ÅäÆÇ¿¡¼­ Ű´­·¹´Ñ¼ö»êÈ­ Ű´­·¹´ÑÀ» °ÅÃÄ »ý±â´Â À¯±â»ê.
  • xanthourenic acid
    ÀÜÅõ·»»ê
    4,8-dihydroxyquinaldic acid. L-try
  • xylic acid
    ÀÚÀϸ°[Å©½Ç]»ê
    °áÁ¤»ê.
  • zinc oxide-ethoxybenzoic acid cement
    EBA ½Ã¸àÆ®
    »êÈ­ ¾Æ¿¬ À¯Áö³î ½Ã¸àÆ®ÀÇ ¾×Áß¿¡¼­ À¯Áö³îÀÇ ´ëºÎºÐÀ» EBA·Î ´ëüÇÑ Ä¡°ú¿ë ½Ã¸àÆ®.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
amino acid analysis Determination and identification of amino acid content of a macromolecule, identification of a specific amino acid in macromolecules, often a mutated protein, identification and quantitation of amino acid content in blood plasma or urine; a key diagnostic aid.
(05 Mar 2000)
amino acid chloromethyl ketones <chemical> Inhibitors of serine proteinases and sulfhydryl group-containing enzymes. They act as alkylating agents and are known to interfere in the translation process.
Pharmacological action: alkylating agents, protein synthesis inhibitor, serine proteinase inhibitors.
(12 Dec 1998)
amino acid dehydrogenases Enzymes catalyzing the oxidative deamination of amino acids to the corresponding oxo (keto) acids; two relatively non-specific varieties exist, l and d, for which l-amino acids and d-amino acids are the respective substrates; the products include NH3 and a reduced hydrogen acceptor (NADH in the l case); amino acid dehydrogenases of greater specificity exist, (e.g., glycine dehydrogenase).
Compare: amino acid oxidases.
(05 Mar 2000)
amino acid isomerases <enzyme> Enzymes that catalyze either the racemization or epimerization of chiral centres within amino acids or derivatives.
Registry number: EC 5.1.1.-
(12 Dec 1998)
amino acid naphthylamidases <enzyme> Registry number: EC 3.4.11.
(12 Dec 1998)
amino acid neurotransmitters Amino acids released by neurons as intercellular messengers. Among the amino acid neurotransmitters are glutamate (glutamic acid) and gaba which are, respectively, the most common excitatory and inhibitory neurotransmitters in the central nervous system.
(12 Dec 1998)
amino acid oxidases Flavoenzymes oxidizing, with O2 and H20, either l-or d-amino acids specifically, to the corresponding 2-keto acids, NH3 and H2O2.
Compare: amino acid dehydrogenases, yellow enzyme.
(05 Mar 2000)
amino acid oxidoreductases <enzyme> A class of enzymes that catalyze oxidation-reduction reactions of amino acids.
Registry number: EC 1.4.
(12 Dec 1998)
amino acid permease <enzyme> A widely distributed group of large Integral membrane proteins, required for the entry of amino acids into cells.
(18 Nov 1997)
amino acid reagent A reagent used in the identification and quantification of amino acids.
(05 Mar 2000)
amino acid receptor <biochemistry> Ligand gated ion channels with specific receptors for amino acid transmitters. An extended protein superfamily that also includes subunits of the nicotinic acetylcholine receptor.
(18 Nov 1997)
amino acid sequence The sequence of amino acids as arrayed in chains, sheets, etc., within the protein molecule. This is referred to as the primary structure of proteins. It is of fundamental importance in determining protein conformation.
(12 Dec 1998)
amino acid substitution The naturally occurring or experimentally induced replacement of one or more amino acids in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties.
(12 Dec 1998)
amino acid transmitter <biochemistry> Amino acids released as neurotransmitter substances from nerve terminals and acting on postsynaptic receptors for example _ aminobutyric acid (GABA) and glycine that are fast inhibitory transmitters in the mammalian central nervous system.
Glutamate and aspartate mediate fast excitatory transmission. Strychnine (for glycine) and bicuculline for GABA) are blocking agents for amino acid action.
(18 Nov 1997)
aminocaproic acid <chemistry> A group of compounds that are derivatives of aminohexanoic acids.
<haematology> An antifibrinolytic agent, used to prevent bleeding in haemophilia, and after heart and prostate surgery when plasminogen or urokinase may be activated.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
ÅëÇÕ°Ë»ö ¿Ï·á